The Trump administration has finalized a rule cutting federal Medicaid and Children’s Health Insurance Program funding for gender-affirming medical care for transgender minors, marking another major federal restriction on transgender health care.
The Centers for Medicare & Medicaid Services announced Tuesday that Medicaid will no longer pay for gender-affirming surgeries or hormone treatments for transgender minors. CHIP will similarly stop covering those treatments for people under 19. The policy is scheduled to take effect Oct. 13.
The change does not amount to a nationwide ban on gender-affirming care. States may still use their own funds to provide coverage, and hospitals and doctors are not prohibited by this rule from providing treatment. But for low-income families who depend on Medicaid or CHIP, eliminating federal support could create another significant barrier to accessing care.
Advocates Warn About the Consequences
The Trevor Project condemned the rule, calling it a “dangerous restriction on doctor-prescribed health care.”
The organization noted that more than 35,000 public comments were submitted after the rule was initially proposed in December. It also emphasized that nothing changes immediately and that advocates still have time to challenge the policy before its October implementation.
The Trevor Project pointed to research associating access to gender-affirming hormone therapy with lower rates of depression, suicidal thoughts and suicide attempts among transgender and nonbinary young people. The organization argued that decisions about treatment should remain with patients, families and medical professionals rather than being dictated through a federal mandate.
The Human Rights Campaign also condemned the rule, arguing that the administration is interfering with medically necessary care. Mental health treatment for transgender youth will remain eligible for Medicaid and CHIP coverage, including when provided as part of their broader gender-related care.
A Federal Pressure Campaign
The rule fits into a broader Trump administration strategy targeting transgender health care. Since returning to office, the administration has pursued multiple policies aimed at restricting transition-related treatment, particularly for minors.
President Donald Trump has also made the political calculation unusually explicit. According to The Washington Post, Trump connected the Medicaid action to the upcoming midterm elections, encouraging voters to remember the administration’s move in November.
That framing puts transgender youth once again in the middle of an election-year political campaign.
For families affected by the rule, however, this is considerably more than a campaign talking point. Medicaid exists largely to provide health coverage to people who otherwise may struggle to afford it. Removing federal funding does not make transgender youth disappear, nor does it make their medical needs disappear.
It simply determines who can afford to continue receiving care.
And with the rule still two months away from taking effect, the next battle is likely to move quickly from Washington’s political arena into the courts.
